The role of external beam irradiation in patients undergoing prostate brachytherapy
- 1 April 2000
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 5 (3) , 112-117
- https://doi.org/10.1016/s1078-1439(99)00053-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinomaCancer, 1998
- Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidanceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- A survey of current clinical practice of permanent prostate brachytherapy in the United StatesInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1997
- 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinomaCancer, 1996
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994